Roger Stanworth
Publications by Year
Research Areas
Hormonal and reproductive studies, Muscle metabolism and nutrition, Pharmacology and Obesity Treatment, Sexual Differentiation and Disorders, Pharmacological Effects and Assays
Most-Cited Works
- → The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes(2007)230 cited
- → Testosterone in Obesity, Metabolic Syndrome and Type 2 Diabetes(2008)117 cited
- → Statin Therapy Is Associated With Lower Total but Not Bioavailable or Free Testosterone in Men With Type 2 Diabetes(2008)88 cited
- → Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes(2008)85 cited
- → Dyslipidaemia is associated with testosterone, oestradiol and androgen receptor CAG repeat polymorphism in men with type 2 diabetes(2011)50 cited
- → The role of androgen receptor CAG repeat polymorphism and other factors which affect the clinical response to testosterone replacement in metabolic syndrome and type 2 diabetes: TIMES2 sub-study(2013)24 cited
- → Controversies and pitfalls in the management of hyperglycaemic crises in critically ill diabetic patients(2011)2 cited
- Use of atorvastatin, but not simvastatin in men with Type 2 diabetes is associated with lower total testosterone levels with no effect on bioavailable or free testosterone(2007)
- HDL cholesterol levels are positively associated with testosterone and are lower with shorter androgen receptor CAG repeat lengths in men with Type 2 diabetes(2007)
- → Androgen Receptor CAG Repeat Polymorphism Modulates Change in Triglycerides, Diastolic Blood Pressure and PSA during Testosterone Replacement Therapy in Men with Metabolic Syndrome or Type 2 Diabetes – The TIMES2 Study(2011)